Publications by authors named "Michelle Poon"

Claim this Profile
C
Cost-effectiveness of ruxolitinib in Singapore for patients with chronic graft-versus-host disease.
Naren Kumar Surendra, Jiamin Ong, Xin Yi Wong, Michelle Poon, Lydia Loke

Expert Rev Pharmacoecon Outcomes Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in relapsed/refractory diffuse large B-cell lymphoma with odronextamab monotherapy.
Elżbieta Iskierka-Jażdżewska, Won Seog Kim, Seok-Goo Cho, Tae Min Kim, Isidro Jarque, Michelle Poon

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deceased donor kidney transplantation in candidates with pre-transplant hematological malignancies: a literature review and recipient allocation proposal in Singapore.
Emmett Tsz Yeung Wong, Ian Tatt Liew, Hein Than, Aloysius Yew Leng Ho, Chandramouli Nagarajan, Michelle Limei Poon

J Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life With Odronextamab Monotherapy for Relapsed/Refractory Follicular Lymphoma in the ELM-2 Study.
Benoit Tessoulin, James Harnett, Seok-Goo Cho, Michał Taszner, Tae Min Kim, Michelle Poon

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront memory T cell add-back with haploidentical TCRαβ-depleted graft in adults with haematological malignancies: a nationwide, multicentre, single-arm, prospective study.
Liang-Piu Koh, Yeh Ching Linn, Yang Liang Boo, Victor Ling, Zi Yi Lim, Michelle Poon

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-Cell Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.
Jason Yongsheng Chan, Ayumi Fujimoto, Esther Wei Yin Chang, Gin Gin Gan, Sen Mui Tan, Michelle Limei Poon

JCO Glob Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A formula using day 4 parameters to predict next-day peripheral blood stem cell yield in healthy haematopoietic stem cell donors.
Jing-Yuan Tan, Liang-Piu Koh, Yeow-Kheong Woon, Kee-Khiang Heng, Angeline Hwee-Yim Tan, Michelle Poon

Bone Marrow Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celebrating 5 years of Women in Lymphoma: a road to equality, diversity, and inclusion in the field.
Anna Sureda, Astrid Pavlosky, Michelle L Poon, Sonali Smith,

Lancet Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore.
Jing Yuan Tan, Victor Wei Teik Ling, Lawrence Cheng Kiat Ng, Cindy Krisnadi, Melinda Si Yuan Tan, Michelle Limei Poon

Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial.
Catherine Thieblemont, Yasmin H Karimi, Herve Ghesquieres, Chan Y Cheah, Michael Roost Clausen, Michelle Limei Poon

Leukemia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular therapy in lymphoma.
Anna Sureda, Pieternella J Lugtenburg, Marie José Kersten, Marion Subklewe, Anne Spanjaart, Michelle Poon

Hematol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized dose selection for the first Waldenström macroglobulinemia patient on the PRECISE CURATE.AI trial.
Agata Blasiak, Lester W J Tan, Li Ming Chong, Xavier Tadeo, Anh T L Truong, Michelle Poon

NPJ Digit Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and prognostic outcomes of angioimmunoblastic T cell lymphoma in an Asian multicenter study.
Esther Wei Yin Chang, Valerie Shiwen Yang, Shin Yeu Ong, Hilda Xueqi Kang, Boon Yee Lim, Michelle Limei Poon, Eileen Poon

Leuk Lymphoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling-a Singaporean experience.
Hui-Lin Chin, Joyce Ching Mei Lam, Dheepa Christopher, Poon Limei Michelle, Benedict Yan Junrong

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations.
Jason Yongsheng Chan, Nagavalli Somasundaram, Nicholas Grigoropoulos, Francesca Lim, Michelle Limei Poon

Discov Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.
Catherine Thieblemont, Tycel Phillips, Herve Ghesquieres, Chan Y Cheah, Michael Roost Clausen, Michelle Limei Poon

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human leukocyte antigen allele and haplotype frequencies in Singapore bone marrow donors and cord blood units.
Alvin Ng Yu-Jin, Grace Benjamin Moshi, Arun Prasath, Marieta Chan, Poon Limei Michelle

Blood Cell Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma.
Chwee Ming Lim, Anthony Liou, Michelle Poon, Liang Piu Koh, Lip Kun Tan

Cancer Immunol Immunother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
Tricia Tay, Nagavalli Somasundaram, Cindy Lim, Lay Poh Khoo, Allan Zhi Kai Goh, Eileen Poon, Michelle Poon

Cancer Rep (Hoboken)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Jing Quan Lim, Dachuan Huang, Jason Yongsheng Chan, Yurike Laurensia, Esther Kam Yin Wong, Michelle L M Poon

Am J Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients.
Bernice Ling Zhi Oh, Nicole Tan, Ruklanthi de Alwis, Kamini Kunasegaran, Zhiwei Chen, Michelle Poon

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Emily Nickles, Bhushan Dharmadhikari, Li Yating, Robert J Walsh, Liang Piu Koh, Michelle Poon

Cancer Immunol Immunother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia.
Yong-Pyo Lee, Sang Eun Yoon, Yuqin Song, Seok Jin Kim, Dok Hyun Yoon, Michelle Poon

Int J Hematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma.
Nurulhuda Mustafa, Adina Huey Fang Nee, Jing Yuan Chooi, Sabrina Hui Min Toh, Tae-Hoon Chung, Michelle Poon

J Immunother Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.
Manavi Sachdeva, Natalie Y L Ngoi, Diana Lim, Michelle L M Poon, Yee Liang Thian

Onco Targets Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis